Oral anti-diabetics for gestational diabetes mellitus – where do we stand?
Background. Oral anti-diabetics in the treatment of gestational diabetes mellitus have had different approaches among time in medical guidelines. The interest in this pregnancy-associated disease is due to the dramatic increase of rates of gestational diabetes but also to the significantly higher sh...
Main Authors: | Delia Cudalba, Corina Gica, Radu Botezatu, Nicolae Gica, Anca Marina Ciobanu, Gheorghe Peltecu, Anca Maria Panaitescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2020-09-01
|
Series: | Romanian Medical Journal |
Subjects: | |
Online Access: | https://rmj.com.ro/articles/2020.3/RMJ_2020_3_Art-02.pdf |
Similar Items
-
Gestational diabetes mellitus and progression to type 2 diabetes
by: Delia Ioana CUDALBA, et al.
Published: (2021-03-01) -
Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes
by: Mitra Behrashi, et al.
Published: (2016-01-01) -
Gestational diabetes: universal or selective screening in pregnancy?
by: Carina Ragea, et al.
Published: (2022-03-01) -
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
by: Rebecca M. Reynolds, et al.
Published: (2017-09-01) -
Screening for Gestational Diabetes during the COVID-19 Pandemic—Current Recommendations and Their Consequences
by: Anca Maria Panaitescu, et al.
Published: (2021-04-01)